Cor Vasa 2011, 53(3):169-182 | DOI: 10.33678/cor.2011.040

Chronická plicní hypertenze. Doporučený diagnostický a léčebný postup České kardiologické společnosti, 2010

Pavel Jansa1,*, Jana Popelová2, Hikmet Al-Hiti3, Jaroslav Lindner4, Aleš Linhart1
1 II. interní klinika kardiologie a angiologie, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy
2 Kardiochirurgické oddělení, Nemocnice Na Homolce
3 Klinika kardiologie, Institut klinické a experimentální medicíny
4 II. chirurgická klinika - kardiovaskulární chirurgie, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha, Česká republika

Published: March 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jansa P, Popelová J, Al-Hiti H, Lindner J, Linhart A. Chronická plicní hypertenze. Doporučený diagnostický a léčebný postup České kardiologické společnosti, 2010. Cor Vasa. 2011;53(3):169-182. doi: 10.33678/cor.2011.040.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537. Go to original source... Go to PubMed...
    2. Riedel M. Klasifikace a nomenklatura plicní hypertenze. Kap Kardiol 2002;4:46-49.
    3. Daniels LB, Krummen DE, Blanchard DG. Echocardiography in pulmonary vascular disease. Cardiol Clin 2004;22:383-399. Go to original source... Go to PubMed...
    4. Neumann RD, Sostman HD, Gottschalk A. Current status of ventilation-perfusion imaging. Semin Nucl Med 1980;X:198-237. Go to original source... Go to PubMed...
    5. Tunariu N, Gibbs SJ, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007;48:680-684. Go to original source... Go to PubMed...
    6. McKie SJ, Hardwick DJ, Reid JH, et al. Features of cardiac disease demonstrated on CT pulmonary angiography. Clin Radiol 2005;60:31-38. Go to original source... Go to PubMed...
    7. Pitton MB, Duber C, Mayer E, et al. Hemodynamic effects of nonionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1996;94:2485-2491. Go to original source... Go to PubMed...
    8. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France. Results from a national registry. Am J Respir Crit Care Med 2006;173:1023-1030. Go to original source... Go to PubMed...
    9. Nichols WC, Koller DL, Slovis B, et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet 1997;15:277-280. Go to original source... Go to PubMed...
    10. Simonneau G, Fartoukh M, Sitbon O, et al. Primary pulmonary hypertension associated with the use of fenfluramines derivatives. Chest 1998;114(Suppl. 3):195S-199S. Go to original source... Go to PubMed...
    11. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-1093. Go to original source...
    12. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991;115:343-349. Go to original source...
    13. Fuster V, Steele PM, Edwards WD, et al. Primary pulmonary hypertension and the importance of thrombosis. Circulation 1984;70:580-587. Go to original source...
    14. Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005;111:3105-3111. Go to original source... Go to PubMed...
    15. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996;334:296-301. Go to original source... Go to PubMed...
    16. Badesch DB, Tapson VF, McGoon MD, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized controlled trial. Ann Intern Med 2000;132: 425-434. Go to original source...
    17. Simonneau G, Barst RJ, Galiè N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2002;165:800-804. Go to original source... Go to PubMed...
    18. Olschewski H, Simonneau G, Galiè N, et al. Inhaled iloprost in severe pulmonary hypertension. N Engl J Med 2002;347:322-329. Go to original source... Go to PubMed...
    19. Barst RJ, McGoon MD, McLaughlin VV, et al. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2003;41:2119-2125. Go to original source...
    20. Channick R, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study. Lancet 2001;358:1119-1123. Go to original source... Go to PubMed...
    21. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896-903. Go to original source... Go to PubMed...
    22. Galiè N, Rubin LJ, Hoeper MM, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 2008;371:2093-2100. Go to original source... Go to PubMed...
    23. Barst RJ, Langleben D, Badesch D, et al. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol 2006;47:2049-2056. Go to original source... Go to PubMed...
    24. Galiè N, Olschewski H, Oudiz RJ, et al. Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation 2008;117:3010-3019. Go to original source... Go to PubMed...
    25. Galiè N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-2157. Go to original source... Go to PubMed...
    26. Galiè N, Brundage BH, Ghofrani HA, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation 2009;119:2894-2903. Go to original source... Go to PubMed...
    27. Benza RL, Park MH, Keogh A, et al. Management of pulmonary arterial hypertension with a focus on combination therapies. J Heart Lung Transplant 2007;26:437-446. Go to original source... Go to PubMed...
    28. Keogh AM, Mayer E, Benza RL, et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol 2009;54 (1 Suppl.):S67-S77. Go to original source... Go to PubMed...
    29. Ghio S, Gavvazi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001;37:183-188. Go to original source...
    30. Klotz S, Wenzelburger F, Stypmann J, et al. Reverzible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant. Ann Thorac Surg 2006;82:1770-1773. Go to original source... Go to PubMed...
    31. Zimpfler D, Zrunek P, Sander S, et al. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist device. Eur J Cardiothorac Surg 2007;31:698-702. Go to original source... Go to PubMed...
    32. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;1:681-686.
    33. Schäfer H, Hasper E, Ewig S, et al. Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factors. Eur Respir J 1998;12:679-684. Go to original source... Go to PubMed...
    34. Galiè N, Kim NH. Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3: 571-576. Go to original source... Go to PubMed...
    35. Hoeper MM, Mayer E, Simonneau G, et al. Chronic thromboembolic pulmonary hypertension. Circulation 2006;113:2011-2020. Go to original source... Go to PubMed...
    36. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-2264. Go to original source... Go to PubMed...
    37. Lang IM, Kerr K. Risk factors for CTEPH. Proc Am Thorac Soc 2006;3:568-570. Go to original source... Go to PubMed...
    38. Riedel M, Staněk V, Widimský J, et al. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-158. Go to original source... Go to PubMed...
    39. Madani MM, Jamieson SW. Technical advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg 2006;18:243-249. Go to original source... Go to PubMed...
    40. Bresser P, Pepke-Zaba J, Jaïs X, et al. Medical therapies for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3: 594-600. Go to original source... Go to PubMed...
    41. Popelová J, Černý Š. Plicní hypertenze u vrozených srdečních vad. Cor Vasa 2009;51:470-477. Go to original source...
    42. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115:1039-1050. Go to original source... Go to PubMed...
    43. Kidd L, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects: results of treatment of patients with ventricular septal defects. Circulation 1993;87(Suppl. 2):I38-I51.
    44. Oechslin EN, Harrison DA, Connelly MS, et al. Mode of death in adults with congenital heart disease. Am J Cardiol 2000;86:1111-1116. Go to original source... Go to PubMed...
    45. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 1958;2:701-709, 755-762. Go to original source...
    46. Baumgartner H, Bonhoeffer P, De Groot N, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010;31:2915-2957. Go to original source... Go to PubMed...
    47. Galiè N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome. A multicenter, double blind, randomized, placebo controlled study (BREATHE-5). Circulation 2006;114:48-54. Go to original source... Go to PubMed...
    48. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation task force on expert consensus documents and the American Heart Association. J Am Coll Cardiol 2009;53: 1573-1619. Go to original source... Go to PubMed...
    49. Goerler H, Simon A, Gohrbandt B, et al. Heart-lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience. Eur J Cardiothorac Surg 2007;32:926-931. Go to original source... Go to PubMed...
    50. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;118: e714-e833.

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes